Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

• Status: Completed
• Trial end date: 2014-08-01

Summary

This study investigates the efficacy and safety profiles of sorafenib in combination of capecitabine and cisplatin, one of standard chemotherapy regimens in patients with advanced gastric cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Asan Medical Center
• Collaborator: Bayer
• Treatments: Capecitabine; Cisplatin; Niacinamide; Sorafenib